Table 2.
Direct comparison results of traditional meta‐analysis
| Number of studies | SMD | I2 | p | Models | |
|---|---|---|---|---|---|
| ACEI vs | |||||
| ARB | 4 | 0.04 (−0.21, 0.28) | 0.00% | .741 | fixed‐effects models |
| BB | 3 | 0.63 (−1.06,−0.20) | 0.00% | .953 | fixed‐effects models |
| CCB | 13 | 0.10 (−0.04, 0.25) | 17.70% | .27 | random‐effects models |
| DIU | 6 | 0.05 (−0.22, 0.33) | 69% | .006 | random‐effects models |
| ARB vs | |||||
| CCB | 4 | −0.82 (−1.22,‐0.42) | 0.00% | .684 | fixed‐effects models |
| BB | 6 | −0.21 (−0.32,−0.10) | 0.00% | .693 | fixed‐effects models |
| DIU | 1 | NA | NA | NA | NA |
| CCB vs | |||||
| BB | 2 | 0.04 (−0.22, 0.29) | 0.00% | .463 | random‐effects models |
| DIU | 7 | −0.16 (−0.44, 0.13) | 28.8% | .230 | random‐effects models |
| BB vs | |||||
| DIU | 2 | 0.20 (−0.68, 0.28) | 61.50% | .107 | fixed‐effects models |
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; BB, beta‐blockers; CCB, calcium channel blocker; DIU, diuretic; NA, not available; SMD, standardized mean difference.